mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.0009 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.002 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |